Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice

被引:117
作者
Matsuo, S
López-Guisa, JM
Cai, XH
Okamura, DM
Alpers, CE
Bumgarner, RE
Peters, MA
Zhang, GQ
Eddy, AA
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
关键词
interstitial fibrosis; plasminogen activator inhibitor-1; macrophage; urokinase; unilateral ureteral obstruction;
D O I
10.1111/j.1523-1755.2005.00327.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis of chronic kidney disease based on its up-regulated expression and on the beneficial effects of PAI-1 inhibition or depletion in experimental models. PAI-1 is a multifunctional protein and the mechanisms that account for its profibrotic effects have not been fully elucidated. Methods. The present study was designed to investigate PAI-1-dependent fibrogenic pathways by comparing the unilateral ureteral obstruction model (UUO) (days 3, 7, and 14) in PAI-I-overexpressing mice (PAI-1 tg) to wild-type mice, both on a C57BL6 background. Results. Following UUO, total kidney PAI-1 mRNA and/or protein levels were significantly higher in the PAI-1 tg mice (N = 6 to 8/group) and fibrosis severity was significantly worse (days 3, 7, and 14), measured both as Sirius red-positive interstitial area (e.g., 10 +/- 3.2% vs. 4.5 +/- 1.0%) (day 14) and total kidney collagen (e.g., 11.1 +/- 1.7 vs. 6.2 +/- 1.3 mu g/mg) (day 14). By day 14, the expression of two normal tubular proteins, E-cadherin and Ksp-cadherin, were significantly lower in the PAI-1 tg mice (3.2 +/- 0.5% vs. 11.7 +/- 5.9% and 2.6 +/- 1.6) vs. 6.2 +/- 0.8%, respectively), implying more extensive tubular damage. At least four fibrogenic pathways were differentially expressed in the PAI-1 tg mice. First, interstitial macrophage recruitment was more intense (P < 0.05 days 3 and 14). Second, interstitial myofibroblast density was greater (P < 0.05 days 3 and 7) despite similar numbers of proliferating tubulointerstitial cells. Third, transforming growth factor-beta 1 (TGF-beta 1) and collagen I mRNA were significantly higher. Finally, urokinase activity was significantly lower (P < 0.05 days 7 and 14) despite similar mRNA levels. Gene microarray studies documented that that the deletion of this single profibrotic gene had far-reaching consequences on renal cellular responses to chronic injury. Conclusion. These data provide further evidence that PAI-1 is directly involved in interstitial fibrosis and tubular damage via two primary overlapping mechanisms: early effects on interstitial cell recruitment and late effects associated with decreased urokinase activity.
引用
收藏
页码:2221 / 2238
页数:18
相关论文
共 52 条
[11]   Molecular basis of renal fibrosis [J].
Eddy, AA .
PEDIATRIC NEPHROLOGY, 2000, 15 (3-4) :290-301
[12]  
Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495
[13]   Plasmin is not protective in experimental renal interstitial fibrosis [J].
Edgtton, KL ;
Gow, RM ;
Kelly, DJ ;
Carmeliet, P ;
Kitching, AR .
KIDNEY INTERNATIONAL, 2004, 66 (01) :68-76
[14]   Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene [J].
Eitzman, DT ;
McCoy, RD ;
Zheng, XX ;
Fay, WP ;
Shen, TL ;
Ginsburg, D ;
Simon, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :232-237
[15]   Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. [J].
Grimm, PC ;
Nickerson, P ;
Jeffery, J ;
Savani, RC ;
Gough, J ;
McKenna, RM ;
Stern, E ;
Rush, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02) :93-97
[16]   Bone marrow-derived progenitor cells in pulmonary fibrosis [J].
Hashimoto, N ;
Jin, H ;
Liu, TJ ;
Chensue, SW ;
Phan, SH .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (02) :243-252
[17]   Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice [J].
Hattori, N ;
Degen, JL ;
Sisson, TH ;
Liu, H ;
Moore, BB ;
Pandrangi, RG ;
Simon, RH ;
Drew, AF .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (11) :1341-1350
[18]   The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism [J].
Hattori, N ;
Mizuno, S ;
Yoshida, Y ;
Chin, K ;
Mishima, M ;
Sisson, TH ;
Simon, RH ;
Nakamura, T ;
Miyake, M .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (03) :1091-1098
[19]   Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor β [J].
Hertig, A ;
Berrou, J ;
Allory, Y ;
Breton, L ;
Commo, F ;
De Beauregard, MAC ;
Carmeliet, P ;
Rondeau, E .
FASEB JOURNAL, 2003, 17 (11) :1904-+
[20]   A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis [J].
Huang, YF ;
Haraguchi, M ;
Lawrence, DA ;
Border, WA ;
Yu, L ;
Noble, NA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :379-388